Published July 27, 2026 at 11:40 AM
MIT Tech Review
Jul 29, 2026, 6:00 AM
Closing the data loop in AI-driven drug discovery

Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug to market takes an average of 10-15 years and co…
Canonical URL for this story: https://www.technologyreview.com/2026/07/27/1139667/closing-the-data-loop-in-ai-driven-drug-discovery/